Alera Investment Advisors’s Acadia Healthcare ACHC Stock Holding History

Alera Investment Advisors’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-11	Closed	–	–	84
2019 Q1	$0	Buy	+11	New	+$312	﹤0.01%	1177

Other funds holding ACHC

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

Ares Management Los Angeles, California $1.52B AUM 12.97% 1-Year Est. Return

Alera Investment Advisors's ACHC Position: Q2 2019 in Review

Alera Investment Advisors sold out of Acadia Healthcare (ACHC) in Q2 2019, closing a stake of 11 shares.

Alera Investment Advisors first reported a position in ACHC in Q1 2019 and held it in 1 quarter. The position peaked at $0 in Q1 2019. 234 funds tracked by Wall St. Rank hold ACHC as of Q2 2019.

Alera Investment Advisors reported no remaining Acadia Healthcare position as of Q2 2019 after selling out during the quarter.
Alera Investment Advisors sold 11 Acadia Healthcare shares in Q2 2019.
Alera Investment Advisors first reported a position in Acadia Healthcare in Q1 2019 and held it in 1 quarter.
Alera Investment Advisors's Acadia Healthcare position peaked at $0 in Q1 2019.
234 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2019.

Based on Alera Investment Advisors's 13F filing for Q2 2019, filed 7 Aug 2019.